JNJ vs VRTX
By Alex · Tickerpine
Johnson & Johnson vs Vertex Pharmaceuticals Incorporated, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | VRTX |
|---|---|---|
| Price | $254.66 | $491.34 |
| Market cap | $613.02B | $124.70B |
| P/E ratio | 29.5 | 29.2 |
| ROE | 26.42% | 24.20% |
| Profit margin | 21.83% | 35.51% |
| Revenue growth | 9.90% | 7.80% |
| Dividend yield | 2.10% | — |
| Beta | 0.26 | 0.31 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs VRTX in plain English
- JNJ is the bigger company — about 4.9× the market cap of VRTX.
- VRTX is cheaper on earnings (P/E 29.2 vs 29.5).
- JNJ earns a higher return on equity (26% vs 24%).
- JNJ is growing revenue faster (10% vs 8%).
- JNJ pays a dividend (2.10%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
VRTX return calculator
See what $1,000 in Vertex Pharmaceuticals Incorporated would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.